Related Experiment Video

Updated: Jul 11, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

5.8K

Editorial: Decoding checkpoint inhibitor-induced immune-related adverse events, volume II

Deborah L Burnett1,2, Megan B Barnet1,2,3, Ania Moxon1

  • 1Immunology Division, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.

Frontiers in Endocrinology
|November 6, 2023
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CTLA -4PD-1 - PD-L1 axiscancer immunotherapyimmune check inhibitor (ICI)immune related adverse effects

More Related Videos

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

10.1K
Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety06:37

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety

Published on: September 15, 2023

636

Related Concept Videos